RGBP... In the Medical field, the first thing to realize that each product has to pass a number of steps! Even though the patents show that the system works, only through laboriously long clinical trials will be the final proof be established or rejected, which will then be a simple response? Either correct the failed part of the Trial, which will take more time, or send it/them to market upon Clinical Trial approval! We are on the
fast track if I read it right, so we should know before maybe March 2023 on a few of the Compounds/Patents? GL